Manipulating and Interrogating Spatial Transcriptomics
Manipulating and Interrogating Spatial Transcriptomics
批准号:
10702050
负责人:
Lei Stanley Qi
金额:
$108.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-07-31
关键词:
Amyotrophic Lateral SclerosisAtlasesAxonBiologyCell physiologyCellsClustered Regularly Interspaced Short Palindromic RepeatsComputer AnalysisDevelopmentDiseaseEmbryoFluorescent in Situ HybridizationFoundationsFragile X SyndromeGoalsImageIn SituIn VitroMediatingMessenger RNAMethodsMonitorNeuronsPathologicPathologyPhysiologicalPlayProtein BiosynthesisRNARNA-Binding ProteinsRegulationResolutionRoleSiteSpinal Muscular AtrophySynapsesTechnologyTherapeuticTimeTranscriptUntranslated RNAaxon guidancecell typedeep learningin vivoinsightmachine learning algorithmnervous system disordernovel strategiessingle moleculespatiotemporaltranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Spatial mRNA organization plays a fundamental role in diverse cellular processes and disease. In large,
compartmentalized cells (e.g., neurons and embryos), subcellular mRNA localization offers a core mechanism
for the spatiotemporal regulation of protein synthesis. Since the initial discovery of subcellular mRNA distribution
in 1983, high-throughput imaging and sequencing methods have revealed that, in many cell types, thousands of
RNAs are localized to distinct compartments. For example, many axonal-related mRNAs in neurons will transport
to the “site of needed” along the very long (>100μm) axon, which likely play an important role in axon
development and local synaptic activities. Furthermore, mounting evidence shows a correlation between
aberrant spatial RNA organization and an increasing number of diseases, including amyotrophic lateral sclerosis
(ALS), fragile X syndrome (FXS), and spinal muscular atrophy (SMA). However, due to a lack of technologies
that allow for the tracking and manipulation of the spatial localization of endogenous mRNAs in primary cells and
in vivo, the mechanism and functional relevance of spatial organization has only been explored for a small
number of mRNAs. In this proposal, we seek to establish a set of technologies as a new foundation to study
spatial RNA biology, by developing an integrated framework that allows for sophisticated computational analysis,
real-time RNA tracking, and programmable spatial manipulation of any endogenous mRNA(s) in situ and in vivo,
on a high-throughput (>1,000 mRNAs in parallel) scale. To achieve this goal, we will start by building a deep
learning framework that can analyze spatially localized RNAs in different cell types and predict their associated
regulatory factors (e.g., RNA motifs, RNA binding proteins). This will provide an atlas of spatial RNA organization
as well as candidate RNAs for functional studies. Next, we will develop two novel approaches, RNA live-cell
fluorescent in situ hybridization (RNA-LiveFISH) for single-molecule, real-time dynamic tracking, and CRISPR-
mediated transcript organization (CRISPR-TO) for programmable manipulation of any target mRNA localization.
The two approaches form a new framework that enables us to study the regulatory mechanism and functional
relevance of subcellular mRNA localization with unprecedented ease and spatiotemporal resolution. Third, we
seek to apply this framework to study the function of mRNA localization in primary neurons, via high-throughput
manipulation of >1,000 mRNAs to uncover functions for axon guidance, growth cone development, and synaptic
activities. Selected functional mRNAs (>100) will be verified in vivo. Finally, we will apply the framework to
investigate the pathological mechanisms of aberrant RNA localization underlying the neurological disease spinal
muscular atrophy (SMA) in vitro and in vivo. We will not only dissect the relationship between mRNA organization
and SMA pathology, but also explore the strategy of modulating RNA localization for potential therapeutics. We
envision that the proposal will lead to new groundbreaking insights into the mechanism and functional roles of
whole-cell mRNA spatial organization for cellular and physiological functions that has not been revealed before.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of multi-color 3D super-localization LiveFISH and LiveFISH PAINT to investigate the chromatin dynamics at any genomic scale
-
批准号:10725002
-
项目类别:
-
资助金额:$42.04万
-
财政年份:2023
-
负责人:Lei Stanley Qi
-
依托单位:
A Cas13d-based screening approach to engineer exhaustion-resistant CAR T cells
-
批准号:10431227
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2022
-
负责人:Lei Stanley Qi
-
依托单位:
A Cas13d-based screening approach to engineer exhaustion-resistant CAR T cells
-
批准号:10571868
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2022
-
负责人:Lei Stanley Qi
-
依托单位:
High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging.
-
批准号:10522013
-
项目类别:
-
资助金额:$43.98万
-
财政年份:2022
-
负责人:Lei Stanley Qi
-
依托单位:
Probing relationships between DNA methylation and cellular senescence with high-throughput CRISPR-based epigenetic editing
-
批准号:10593233
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2022
-
负责人:Lei Stanley Qi
-
依托单位:
High resolution dissection of oncogene enhancer networks via CRISPR screening and live-cell imaging.
-
批准号:10671756
-
项目类别:
-
资助金额:$44.24万
-
财政年份:2022
-
负责人:Lei Stanley Qi
-
依托单位:
Examining COVID-19 in Down Syndrome Patients Using Human iPSC-Derived Organoids
-
批准号:10241207
-
项目类别:
-
资助金额:$66.88万
-
财政年份:2021
-
负责人:Lei Stanley Qi
-
依托单位:
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
-
批准号:10518663
-
项目类别:
-
资助金额:$68.39万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in DCM - Diversity Supplement
-
批准号:10730997
-
项目类别:
-
资助金额:$3.39万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
-
批准号:10852761
-
项目类别:
-
资助金额:$9.2万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
-
批准号:10444652
-
项目类别:
-
资助金额:$69.69万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Elucidating CHD in Down Syndrome with Cardiac Organoids and 3D Genome Architecture
-
批准号:10852469
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated Cardiomyopathy
-
批准号:10627921
-
项目类别:
-
资助金额:$69.06万
-
财政年份:2018
-
负责人:Lei Stanley Qi
-
依托单位:
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
-
批准号:10454967
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2015
-
负责人:Lei Stanley Qi
-
依托单位:
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
-
批准号:9814475
-
项目类别:
-
资助金额:$68.85万
-
财政年份:2015
-
负责人:Lei Stanley Qi
-
依托单位:
Genome Editing of Human iPSCs to Study Inherited Hypertrophic Cardiomyopathy
-
批准号:10213111
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2015
-
负责人:Lei Stanley Qi
-
依托单位:
A novel RNA-guided platform for sequence-specific cell reprogramming
-
批准号:8928376
-
项目类别:
-
资助金额:$33.32万
-
财政年份:2013
-
负责人:Lei Stanley Qi
-
依托单位:
A novel RNA-guided platform for sequence-specific cell reprogramming
-
批准号:8609325
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2013
-
负责人:Lei Stanley Qi
-
依托单位:
A novel RNA-guided platform for sequence-specific cell reprogramming
-
批准号:9349361
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2013
-
负责人:Lei Stanley Qi
-
依托单位:
A novel RNA-guided platform for sequence-specific cell reprogramming
-
批准号:8914999
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2013
-
负责人:Lei Stanley Qi
-
依托单位:
海外基金